Pharma major Lupin said it has bought the worldwide rights for the Goanna Brand, under which therapeutic oils and ointments are marketed. This acquistion was done through Lupin's Australian subsidary Generic Health.
This acquistion will allow, Lupin to strengthens its postion in Australian market. The brand is being sold by 83% pharmacies in Australia.
Vinod Dhawan, president, AAMLA and Business Development, Lupin said, “The Goanna acquistion demonstrates Lupin’s sucess in building its brand francishe and equity globally.”
Shares of Lupin were trading at Rs 442.45, up 0.73% on BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app